Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks.
J Invest Dermatol
; 139(5): 1054-1062, 2019 05.
Article
in En
| MEDLINE
| ID: mdl-30508547
Full text:
1
Database:
MEDLINE
Main subject:
Psoriasis
/
Cardiovascular Diseases
/
Antibodies, Monoclonal, Humanized
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2019
Type:
Article